NYSE:HIMS

Hims & Hers Health - Class A Stock Insider Trading

etoro logo Buy HIMS
*Your capital is at risk
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026

Hims & Hers Health - Class A Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -6.15. In total, the insiders bought 1.66M and sold 544.74K HIMS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-6.15
Buy 1.66M shares
Sell 544.74K shares
80% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jun 15, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (80% buys).

Historical Insider Trades

Date Type Person Role Amount
Jun 11, 2026
Buy
Restricted Stock Unit
M-Exempt
Schultz Kare
Director
Director 3 656
Value: $105.5K
Jun 11, 2026
Buy
Class A Common Stock
M-Exempt
Perez Garcia Andrea G
Director
Director 3 656
Value: $105.5K
Jun 11, 2026
Buy
Class A Common Stock
M-Exempt
Schultz Kare
Director
Director 3 656
Value: $105.5K
Jun 11, 2026
Buy
Class A Common Stock
M-Exempt
Wells David B
Director
Director 3 656
Value: $105.5K
Jun 11, 2026
Buy
Class A Common Stock
M-Exempt
Autor Deborah M.
Chief Policy Officer
Officer 3 656
Value: $105.5K
Jun 11, 2026
Buy
Common Stock
J-Other
Amoo-gottfried Kofi Owusu
Director 0
Value: $0
Jun 11, 2026
Buy
Restricted Stock Unit
M-Exempt
Autor Deborah M.
Chief Policy Officer
Officer 3 656
Value: $105.5K
Jun 11, 2026
Buy
Class A Common Stock
M-Exempt
Pendarvis Christiane
Director
Director 3 656
Value: $105.5K
Jun 11, 2026
Buy
Restricted Stock Unit
M-Exempt
Cosgrove Delos M.
Director
Director 3 656
Value: $105.5K
Jun 11, 2026
Buy
Class A Common Stock
M-Exempt
Cosgrove Delos M.
Director
Director 3 656
Value: $105.5K
May 26, 2026
Buy
Class A Common Stock
P-Purchase
Wells David B
Director
Director 48 400
Value: $1.17M
May 20, 2026
Buy
Restricted Stock Unit
A-Award
Carroll Patrick Harrison
Chief Medical Officer
Officer 435
Value: $10.0K
May 20, 2026
Buy
Restricted Stock Unit
A-Award
Wells David B
Director
Director 957
Value: $22.0K
May 20, 2026
Buy
Restricted Stock Unit
A-Award
Payne Christopher D
Director
Director 647
Value: $14.9K
May 18, 2026
Sell
Class A Common Stock
S-Sale
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 7 950
Value: $187.9K
May 18, 2026
Buy
Class A Common Stock
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 7 950
Value: $39.8K
May 18, 2026
Buy
Stock Option (right to buy)
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 7 950
Value: $39.8K
Apr 20, 2026
Buy
Stock Option (right to buy)
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 7 000
Value: $80.7K
Apr 20, 2026
Sell
Class A Common Stock
S-Sale
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 19 645
Value: $588.6K
Apr 20, 2026
Buy
Class A Common Stock
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 7 000
Value: $80.7K
Apr 20, 2026
Sell
Class A Common Stock
S-Sale
Boughton Soleil
Chief Legal Officer
Officer 9 463
Value: $283.9K
Apr 20, 2026
Buy
Class A Common Stock
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 5 553
Value: $27.8K
Apr 20, 2026
Buy
Stock Option (right to buy)
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 5 553
Value: $27.8K
Apr 17, 2026
Sell
Class A Common Stock
S-Sale
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 18 005
Value: $501.2K
Apr 17, 2026
Buy
Class A Common Stock
M-Exempt
Okupe Oluyemi
Chief Financial Officer
C-Suite Officer 6 184
Value: $31.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HIMS & HERS HEALTH INC - CLASS A
Hims & Hers Health - Class A
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmeti...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE